Breakthroughs start with single strands.

Unlocking new therapies built with single-stranded DNA

CPTx is focused on solving critical challenges in genetic medicine to unlock therapies that are safe, effective and accessible. 

With our in vivo CAR-T platform program, we plan to bring life-saving cancer and autoimmune treatments to millions of patients for whom current therapies are inadequate, too complex, or too expensive. 

We are also developing a completely new approach to gene delivery, a proprietary self-delivering gene carrier technology built with single-stranded DNA that has the potential to broadly expand the scope, adoption, and access to gene therapies, overcoming critical limitations of existing technologies. 

At CPTx, we have innovated unique manufacturing processes together with manufacturing infrastructure that allow us to synthesize both long and short sequence, high-purity ssDNA at industrial scales. Paired with our deep technical and biological expertise, CPTx is uniquely positioned to deliver.